We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $733M
1-Year Est. Return 327.32%
This Fund
S&P 500
This Quarter Est. Return
+30.63%
1 Year Est. Return
+327.32%
3 Year Est. Return
+1,033.66%
5 Year Est. Return
+1,660.59%
10 Year Est. Return
–
AUM
$320M
AUM Growth
-$34.7M
Cap. Flow
-$76.2M
Cap. Flow %
-23.82%
Top 10 Hldgs %
60.71%
Holding
47
New
7
Increased
14
Reduced
8
Closed
9

Top Buys

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$13.9M
2
BLZE icon
Backblaze
BLZE
+$12.2M
3
VSTM icon
Verastem
VSTM
+$10.5M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$6.73M
5
COYA icon
Coya Therapeutics
COYA
+$3.76M

Top Sells

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$13.8M
2
GLW icon
Corning
GLW
+$7.11M
3
CLRB icon
Cellectar Biosciences
CLRB
+$6.84M
4
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$4.52M
5
DCTH icon
Delcath Systems
DCTH
+$4.19M

Sector Composition

Rank Sector Weight
1 Healthcare 53.56%
2 Technology 20.77%
3 Industrials 8.63%
4 Communication Services 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLW icon
1
CALL
Corning
GLW
$107B
$32.1M 10.03%
675,000
– –
MRVL icon
2
CALL
Marvell Technology
MRVL
$149B
$22.1M 6.91%
+200,000
New +$18.6M
PSNL icon
3
Personalis
PSNL
$1.23B
$22M 6.87%
3,799,064
-200,000
-5% -$923K
MYO icon
4
Myomo
MYO
$36.4M
$21.8M 6.81%
3,381,567
+602,719
+22% +$2.93M
ARQ icon
5
Arq
ARQ
$81.6M
$21.3M 6.67%
2,817,078
– –
DCTH icon
6
Delcath Systems
DCTH
$400M
$16.7M 5.22%
1,385,389
-397,101
-22% -$4.19M
MRVL icon
7
Marvell Technology
MRVL
$149B
$16.6M 5.18%
+150,000
New +$13.9M
SCPH
8
DELISTED
scPharmaceuticals
SCPH
$14.8M 4.62%
4,174,367
+50,000
+1% +$192K
VSTM icon
9
Verastem
VSTM
$521M
$13.8M 4.31%
+2,665,043
New +$10.5M
LPTH icon
10
Lightpath Technologies
LPTH
$591M
$13.1M 4.11%
3,723,932
– –
TARS icon
11
Tarsus Pharmaceuticals
TARS
$2.52B
$12.4M 3.89%
224,713
+20,300
+10% +$922K
ELUT icon
12
Elutia
ELUT
$39.8M
$11.5M 3.6%
3,074,675
+564,233
+22% +$2.19M
BLZE icon
13
Backblaze
BLZE
$695M
$10.8M 3.39%
+1,800,000
New +$12.2M
BDSX icon
14
Biodesix
BDSX
$215M
$9.46M 2.96%
308,991
+25,000
+9% +$736K
BKTI icon
15
BK Technologies
BKTI
$293M
$9.2M 2.88%
268,180
-14,592
-5% -$445K
XERS icon
16
Xeris Biopharma Holdings
XERS
$1.45B
$8.73M 2.73%
2,574,846
+389,192
+18% +$1.25M
TELA icon
17
TELA Bio
TELA
$30.9M
$8.04M 2.51%
2,662,785
+193,412
+8% +$544K
COYA icon
18
Coya Therapeutics
COYA
$92.9M
$6.88M 2.15%
1,201,152
+551,725
+85% +$3.76M
ZVRA icon
19
Zevra Therapeutics
ZVRA
$568M
$6.58M 2.06%
+788,614
New +$6.73M
ELVA
20
Electrovaya
ELVA
$375M
$6.26M 1.96%
2,525,099
+77,473
+3% +$181K
IPWR icon
21
Ideal Power
IPWR
$56.3M
$6.22M 1.94%
823,315
+123,315
+18% +$873K
THTX
22
DELISTED
Theratechnologies
THTX
$5.48M 1.71%
3,026,569
-698,635
-19% -$950K
IDN icon
23
Intellicheck
IDN
$74.7M
$4.53M 1.42%
1,617,696
-150,036
-8% -$378K
GLW icon
24
Corning
GLW
$107B
$3.56M 1.11%
75,000
-150,000
-67% -$7.11M
PYPD icon
25
PolyPid
PYPD
$77.5M
$2.51M 0.78%
827,867
+148,199
+22% +$487K
1
2

Similar funds

GFI
Global Frontier Investments Charleston, South Carolina $732M AUM 8.6% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $732M AUM 28.13% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $732M AUM 29.73% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
GIC
GFI Investment Counsel Toronto, Ontario, Canada $731M AUM 3.86% 1-Year Est. Return
CT
Colonial Trust Spartanburg, South Carolina $735M AUM 18% 1-Year Est. Return
TWP
TFO Wealth Partners Maumee, Ohio $735M AUM 21.07% 1-Year Est. Return
GWS
Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

AIGH Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, AIGH Capital Management held 47 positions worth $320M, down 9.8% from $355M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

AIGH Capital Management withdrew a net $76.2M in Q4 2024, closing 9 positions and reducing 8 holdings. Its most notable exit was Digital Turbine, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, AIGH Capital Management opened a new position in Marvell Technology worth $16.6M.

  • AIGH Capital Management's largest Q4 2024 buy was Marvell Technology: 150,000 shares worth $16.6M.
  • AIGH Capital Management added most to Coya Therapeutics in Q4 2024, an estimated $3.76M increase.
  • AIGH Capital Management's biggest Q4 2024 reduction was Corning, cutting an estimated $7.11M.
  • AIGH Capital Management fully exited Digital Turbine in Q4 2024, selling an estimated $13.8M.
  • AIGH Capital Management's ten largest holdings make up 61% of its $320M portfolio in Q4 2024.
  • AIGH Capital Management opened 7 new positions and closed 9 in Q4 2024.
  • AIGH Capital Management's portfolio value fell 9.8% quarter-over-quarter to $320M.

Based on AIGH Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.